Результаты поиска

'''Fluanisone''' is a [[typical antipsychotic]] and [[sedative]] of the [[butyrophenone]] [[chemical class]].<ref>{{cite book | vauthors = Janssen PA | chapter = H {{Antipsychotics}} ...

...' and '''Impromen''' among others, is a [[typical antipsychotic]] of the [[butyrophenone]] group which is used in the treatment of [[schizophrenia]].<ref name="Elks {{Pharmacokinetics of long-acting injectable antipsychotics}} ...

{{Pharmacokinetics of long-acting injectable antipsychotics}} * [[List of antipsychotics#Antipsychotic esters|List of antipsychotics § Antipsychotic esters]] ...

'''Aceperone''' is a [[neuroleptic]] drug of the [[butyrophenone]] class. It is an [[Adrenergic receptor|α-noradrenergic]] blocking drug d {{Antipsychotics}} ...

...re|structurally]] related to both [[tricyclic]]s like [[imipramine]] and [[butyrophenone]]s like [[haloperidol]].<ref name="isbn3-527-31058-4"/> {{Antipsychotics}} ...

==={{anchor|N05AD}}N05AD [[Butyrophenone]] derivatives=== ==={{anchor|N05AX}}N05AX Other antipsychotics=== ...

'''Azaperone''' is a [[pyridinylpiperazine]] and [[butyrophenone]] [[neuroleptic]] [[drug]] with [[sedative]] and [[antiemetic]] effects, wh {{Antipsychotics}} ...

{{Pharmacokinetics of long-acting injectable antipsychotics}} * [[List of antipsychotics#Antipsychotic esters|List of antipsychotics § Antipsychotic esters]] ...

...3 | date = October 1963 | pmid = 14092279 }}</ref> It is a highly potent [[butyrophenone]] derivative and is the most potent neuroleptic in the European market, wit {{Antipsychotics}} ...

...authors=Sumiyoshi T, Suzuki K, Sakamoto H | title = Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy | ...receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used | journal = Japanese Journal of Pharmacology | volume = 69 | ...

...en Treating Acute Agitation in the Emergency Department With Intramuscular Antipsychotics | journal = The Journal of Emergency Medicine | volume = 56 | issue = 5 | p Discovered at [[Janssen Pharmaceutica]] in 1961, droperidol is a [[butyrophenone]] which acts as a potent [[dopamine antagonist|D₂ (dopamine rece ...

...to induce hyperprolactinemia in a dose-dependent manner similar to typical antipsychotics.<ref>{{Cite journal|last1=Kelly|first1=Deanna L.|last2=Wehring|first2=Heidi ...hotic]]s: [[phenothiazine]]s such as [[chlorpromazine]] (Thorazine), and [[butyrophenone]]s such as [[haloperidol]] (Haldol); [[atypical antipsychotic]]s such as [[ ...

...tures indicated in this disease), and currently thought to be a reason why antipsychotics with 5HT2C antagonistic properties improves [[Schizophrenia#Positive and ne ...advanced schizophrenia is likely impossible through the use of any modern antipsychotics, so the value of early intervention cannot be stressed enough. ...

In a 2013 comparison of 15 antipsychotics in schizophrenia, haloperidol demonstrated standard effectiveness. It was 1 ...rnal | vauthors = Tauscher J, Kapur S | title = Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies | journal = CNS Drugs | ...

...ar to those of centrally permeable D₂ receptor antagonists like antipsychotics.<ref name="pmid24660005">{{cite journal | vauthors = Ferrier J | title = Do ...txundi U, Erezuma I, Hernandez R, Medrano J, Garcia M, Aguirre C | title = Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance databas ...

| Drugs.com = {{Drugs.com|drug-class|antipsychotics}} '''Antipsychotics''', previously known as neuroleptics<ref name=Fin2009>{{cite book| vauthors ...